tiprankstipranks
Tenaya Therapeutics (TNYA)
NASDAQ:TNYA
US Market
TNYA
Tenaya Therapeutics
RESEARCH TOOLSreports
Want to see TNYA full AI Analyst Report?

Tenaya Therapeutics (TNYA) Stock News & Sentiment

3,140 Followers
Tenaya’s TN-401: Differentiated PKP2 Gene Therapy Opportunity Underpins Favorable Risk–Reward and Buy Rating
Premium
Ratings
Tenaya’s TN-401: Differentiated PKP2 Gene Therapy Opportunity Underpins Favorable Risk–Reward and Buy Rating
19d ago
TNYA
Advancing Pipeline and Regulatory Clarity Underpin Buy Rating on Tenaya Therapeutics
Premium
Ratings
Advancing Pipeline and Regulatory Clarity Underpin Buy Rating on Tenaya Therapeutics
2M ago
TNYA
Tenaya Therapeutics: Early Gene Therapy Promise, Cash Runway to 2H27, and 2026 Data Catalysts Support Buy Rating and $5 Target
Premium
Ratings
Tenaya Therapeutics: Early Gene Therapy Promise, Cash Runway to 2H27, and 2026 Data Catalysts Support Buy Rating and $5 Target
2M ago
TNYA
Tenaya Therapeutics: Gene Therapy Momentum and De‑Risking Clinical Milestones Support Buy Rating
Premium
Ratings
Tenaya Therapeutics: Gene Therapy Momentum and De‑Risking Clinical Milestones Support Buy Rating
2M ago
TNYA
3 Best Stocks to Buy Now, 3/10/2026, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 3/10/2026, According to Top Analysts
2M ago
EVAX
IMRX
TN-301: Differentiated HDAC6 Inhibitor Offering Dual Skeletal and Cardiac Benefit in DMD with Multiple Near-Term Catalysts
Premium
Ratings
TN-301: Differentiated HDAC6 Inhibitor Offering Dual Skeletal and Cardiac Benefit in DMD with Multiple Near-Term Catalysts
2M ago
TNYA
Tenaya Therapeutics: Alnylam Partnership Validates Cardiovascular Platform and Supports Long-Term Buy Thesis
Premium
Ratings
Tenaya Therapeutics: Alnylam Partnership Validates Cardiovascular Platform and Supports Long-Term Buy Thesis
2M ago
TNYA
More TNYA News >

TNYA News on the Web

Tenaya Therapeutics Duchenne muscular dystrophy treatment granted orphan status
TipRanks News
Bullish
Tenaya’s TN-401: Differentiated PKP2 Gene Therapy Opportunity Underpins Favorable Risk–Reward and Buy Rating
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (TNYA) and Sagimet Biosciences, Inc. Class A (SGMT)
TipRanks News
Bullish
Advancing Pipeline and Regulatory Clarity Underpin Buy Rating on Tenaya Therapeutics
TipRanks News
Bullish
Tenaya Therapeutics: Early Gene Therapy Promise, Cash Runway to 2H27, and 2026 Data Catalysts Support Buy Rating and $5 Target
TipRanks News
Bullish
Tenaya Therapeutics: Gene Therapy Momentum and De‑Risking Clinical Milestones Support Buy Rating
TipRanks News
Bullish
Tenaya Therapeutics reports Q4 EPS (12c), consensus (12c)
TipRanks News
Bullish
3 Best Stocks to Buy Now, 3/10/2026, According to Top Analysts
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
TNYA
Sector Average
Media Buzz
This Week1 articles
Weekly Average0.25 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TNYA’s Media Buzz Sentiment?
1 articles about TNYA were published this week. In an average week, 0.25 articles are published.
    What is TNYA’s weekly average amount of articles?
    In an average week, 0.25 articles about TNYA are published.
      What is TNYA’s News Sentiment?
      100% of articles about TNYA were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week